Edward Tobinick MD Blog

Comments: 0

Progressive improvement 5 years after cardiac arrest after treatment by Edward Tobinick, M.D.

Progressive improvements in speech and cognition after perispinal etanercept treatment by Dr. Tobinick 5 years after cardiac arrest. Filmed at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida, February 10, 2020.

Request a consultation today
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use

Posted by INR PLLC on Tuesday, February 18, 2020 at 5:37 pm
Filed under Blog Posts, Brain Research, INR News, Scientific Publications, Uncategorized · Tagged with #cardiac arrest, #stroke breakthrough, Aphasia, Edward Tobinick, Institute of Neurological Recovery, Perispinal Etanercept, Stroke Recovery, Stroke Rehabilitation, Stroke Treatment, Tobinick

Comments: 0

Immediate resolution of stroke pain after treatment, February 12, 2020

Perispinal etanercept treatment by Dr. Tobinick. Filmed at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida, February 12, 2020.

Posted by INR PLLC on Monday, February 17, 2020 at 3:08 pm
Filed under Blog Posts, Brain Research, INR News, Scientific Publications, Uncategorized · Tagged with #post-stroke fatigue, #stroke breakthrough, Edward Tobinick, Institute of Neurological Recovery, Perispinal Etanercept, Post Stroke Pain, Stroke Recovery, Stroke Rehabilitation, Stroke Treatment, Tobinick

Comments: 0

16 months after stroke, multiple improvements after treatment by Edward Tobinick, M.D.

Perispinal etanercept treatment by Dr. Tobinick, followed by rapid improvements in awareness, walking, aphasia, grip strength, and comprehension/reading. Filmed at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida, on January 29, 2020.

Posted by INR PLLC on Monday, February 17, 2020 at 1:46 pm
Filed under Blog Posts, Brain Research, INR News, Scientific Publications, Uncategorized · Tagged with #stroke breakthrough, Aphasia, Edward Tobinick, Institute of Neurological Recovery, Perispinal Etanercept, Stroke Recovery, Stroke Rehabilitation, Stroke Treatment, Tobinick

Comments: 0

Improvements after treatment by Edward Tobinick, M.D., 22 months after brain injury due to cardiac arrest

Perispinal etanercept treatment by Dr. Tobinick. Filmed at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida, on January 21, 2020.

Posted by INR PLLC on Thursday, January 30, 2020 at 1:34 pm
Filed under Blog Posts, Brain Research, INR News, Scientific Publications, Uncategorized · Tagged with #cardiac arrest, #stroke breakthrough, Edward Tobinick, Institute of Neurological Recovery, Perispinal Etanercept, Stroke Recovery, Stroke Rehabilitation, Stroke Treatment, Tobinick

Comments: 0

Multiple improvements 2.5 years after stroke, after treatment by Edward Tobinick, M.D., in January, 2020

Perispinal etanercept treatment by Dr. Tobinick. Filmed at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida, in January 2020.

Posted by INR PLLC on Friday, January 17, 2020 at 4:55 pm
Filed under Blog Posts, Brain Research, INR News, Scientific Publications, Uncategorized · Tagged with #stroke breakthrough, Edward Tobinick, Institute of Neurological Recovery, Perispinal Etanercept, Stroke Recovery, Stroke Rehabilitation, Stroke Treatment, Tobinick

About Dr. Tobinick

Edward Lewis Tobinick is an American physician who is the inventor of the perispinal etanercept treatment for chronic stroke pain whose efficacy has been established by a randomized, double-blind, placebo-controlled clinical trial published in January 2020.

Dr. Tobinick graduated Phi Beta Kappa and Magna Cum Laude with honors in biology from Brandeis University in Waltham, Massachusetts and received his M.D. from the University of California San Diego School of Medicine in La Jolla, California.

The published scientific articles documenting unprecedented neurological effects produced by the novel method of drug delivery invented by Dr. Tobinick have been cited by hundreds of scientists from academic centers around the world.

Dr. Tobinick's breakthrough stroke treatment has been used to treat patients from every continent in the world, including from the U.S., Canada, England, Scotland, Wales, Ireland, Mexico, Trinidad, Jamaica, Haiti, Bahamas, Guatemala, Belize, Brazil, Columbia, Bolivia, Uruguay, Ecuador, Chile, Peru, Germany, France, Spain, Italy, Portugal, Belgium, Netherlands, Switzerland, Bulgaria, Romania, Ukraine, Poland, Denmark, Sweden, Norway, Iceland, Gibraltar, Uzbekistan, Turkey, Israel, Saudi Arabia, UAE, Oman, Iraq, Egypt, Morocco, Nigeria, Ghana, Cameroon, South Africa, Mozambique, Kenya, Mauritius, India, Bangladesh, Thailand, Vietnam, China, Hong Kong, Japan, Indonesia, Malaysia, Philippines, Australia, New Zealand, Papua New Guinea, Fiji, and the Cook Islands.

In 2018 the Australian Minister of Health, Hon. Greg Hunt, designated substantial funds to study Dr. Tobinick's breakthrough stroke treatment in Australia.

Dr. Tobinick has been an invited ad hoc reviewer for the journals Brain Research, Clinical Drug Investigation, CNS Drugs, Current Alzheimer Research, Experimental Neurology, Future Neurology, Journal of Neurochemistry, Journal of Neuroimmunology, Neuroscience, and Pharmaceutical Medicine and a member of the Editorial Board of the Journal of Neuroinflammation.

More Info